Split deliveries can align PAM flocculant supply with consumption and storage capacity. They do not guarantee that every shipment will be available on demand. A workable plan separates forecast volume, confirmed orders, delivery lead time and the technical identity that must remain unchanged across lots.
Forecast consumption from operating conditions
Use recent demand alongside expected production, shutdowns and seasonal feed changes. State whether the forecast is dry product or active polymer and reconcile it with actual warehouse issues. Avoid purchasing from a fixed monthly average if the plant has large peaks. Include the minimum approved reserve that operations need during a delay. The bulk clarification guide explains how preparation capacity and usable stock constrain a sensible shipment size.
Separate planning estimates from shipment commitments
Clarify which volumes are forecasts and which are confirmed orders, with the supplier’s acknowledged timing and commercial scope. Agree how far ahead changes must be discussed, without inventing a guaranteed lead time. Confirm destination, package type and unloading arrangements for each delivery. A framework quantity does not by itself establish the stock, freight booking or remaining shelf life of a particular lot. Obtain those details when the release order is confirmed.
Preserve grade identity across the schedule
Use the same approved product code and document any authorized changes before dispatch. Require lot markings and appropriate accompanying documents so receiving staff can associate each delivery with its approval. Retain samples where the treatment risk warrants comparison. Do not silently use split shipments to alternate between unqualified grades. The replacement approval guide applies whenever the supplier proposes a materially different product, even under an existing supply arrangement.
Rotate stock and review actual demand
Issue material in a controlled order consistent with supplier storage and shelf-life advice. Keep packages dry and identifiable, and avoid mixing untraceable remnants into new deliveries. Compare actual consumption and treatment performance with the forecast before confirming the next release. If demand falls, discuss timing while sufficient flexibility remains; if it rises, verify the earlier delivery rather than assuming extra supply is automatic. A supply plan should be revised from evidence, not left unchanged because its annual total looks convenient.
Purchase review worksheet
Complete the evidence column with measured values, observations or an agreed document reference. An unanswered item is a reason to clarify the sample or quotation, not to assume that two products are equivalent. Keep the same worksheet with the trial record so the purchasing and operating teams approve the same conditions.
| Review item | Evidence to obtain | Decision before ordering |
|---|---|---|
| Forecast | Normal demand, peaks and approved reserve | Release volumes reflect usable operating cover |
| Confirmation | Order, destination, package and acknowledged timing | Each shipment has a defined commercial scope |
| Traceability | Approved code, lot documents and stock rotation | Repeat deliveries remain technically controlled |
Request a focused PAM flocculant quotation
Send the feed source, solids concentration, pH or conductivity, operating temperature and separator type alongside the monthly quantity, package preference and destination. Include the specific observations in the worksheet above. If a current grade is being replaced, provide its available technical data and the active dose rather than only the trade name. Commercial availability, sample quantities and delivered terms should be confirmed for the selected product, not inferred from an illustrative application.
Arrange the comparison through the PAM trial planner and review quality documents and supply requirements before committing to a shipment. Gongyi Xinqi Polymer Co., Ltd. can review the application information and discuss a suitable sample range. Application suitability remains conditional on representative testing; a polymer recommendation is not a guarantee of plant performance or regulatory compliance.

